Read Anywhere and on Any Device!

Subscribe to Read | $0.00

Join today and start reading your favorite books for Free!

Read Anywhere and on Any Device!

  • Download on iOS
  • Download on Android
  • Download on iOS

Anti-fatigue effect of Neurotropin in chronic fatigue syndrome-NIH performed double-blind studies of Neurotropin in fibromyalgia patients (protocol number: 06-NR-0229)-

Anti-fatigue effect of Neurotropin in chronic fatigue syndrome-NIH performed double-blind studies of Neurotropin in fibromyalgia patients (protocol number: 06-NR-0229)-

Katsuhiro Toda
0/5 ( ratings)
The efficacy of Neurotropin for chronic fatigue syndrome is presented. Eleven CFS patients received NT as 4-8 tablets per day . Subjective fatigue at the initial visit was considered 100, and subjective fatigue after treatment was an index of therapeutic efficacy. Patients whose subjective fatigue decreased to 30% or less with NT alone, or NT and other medicine, and whose subjective fatigue did not recur after discontinuation of treatment were 2 and 1, respectively. Patients whose subjective fatigue decreased to 30% or less with NT alone, or NT and other medicine, and whose medication was continued were 2 and 1, respectively. Patients whose subjective fatigue decreased to 90% or less but did not decrease to 30% or less with NT alone, or NT and other medicine were 1 and 1, respectively. One patient discontinued treatment because of adverse effects of NT. Two patients discontinued treatment because of adverse effects during administration of NT and other medicine.
In Japan, NT is widely used for chronic pain, such as low back pain, neck-shoulder-arm syndrome, osteoarthritis, subacute myelo-optico-neuropathy, postherpetic neuralgia, and complex regional pain syndrome. Analgesic effects of NT are thought to be the activation of a descending pain inhibitory system; however, it cannot account for the improvement of fatigue. Viral infection theory is a popular hypothesis in the etiology of CFS. NT may activate antivirus action.
Language
English
Pages
10
Format
Kindle Edition
Release
March 29, 2013

Anti-fatigue effect of Neurotropin in chronic fatigue syndrome-NIH performed double-blind studies of Neurotropin in fibromyalgia patients (protocol number: 06-NR-0229)-

Katsuhiro Toda
0/5 ( ratings)
The efficacy of Neurotropin for chronic fatigue syndrome is presented. Eleven CFS patients received NT as 4-8 tablets per day . Subjective fatigue at the initial visit was considered 100, and subjective fatigue after treatment was an index of therapeutic efficacy. Patients whose subjective fatigue decreased to 30% or less with NT alone, or NT and other medicine, and whose subjective fatigue did not recur after discontinuation of treatment were 2 and 1, respectively. Patients whose subjective fatigue decreased to 30% or less with NT alone, or NT and other medicine, and whose medication was continued were 2 and 1, respectively. Patients whose subjective fatigue decreased to 90% or less but did not decrease to 30% or less with NT alone, or NT and other medicine were 1 and 1, respectively. One patient discontinued treatment because of adverse effects of NT. Two patients discontinued treatment because of adverse effects during administration of NT and other medicine.
In Japan, NT is widely used for chronic pain, such as low back pain, neck-shoulder-arm syndrome, osteoarthritis, subacute myelo-optico-neuropathy, postherpetic neuralgia, and complex regional pain syndrome. Analgesic effects of NT are thought to be the activation of a descending pain inhibitory system; however, it cannot account for the improvement of fatigue. Viral infection theory is a popular hypothesis in the etiology of CFS. NT may activate antivirus action.
Language
English
Pages
10
Format
Kindle Edition
Release
March 29, 2013

More books from Katsuhiro Toda

Rate this book!

Write a review?

loader